Daniel B Mark1, Michael S Lauer. 1. Outcomes Research and Assessment Group, Duke Clinical Research Institute, Durham, NC 27715, USA. daniel.mark@duke.edu
Authors: M Wojewoda; K Przyborowski; B Sitek; A Zakrzewska; L Mateuszuk; J A Zoladz; S Chlopicki Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2016-12-03 Impact factor: 3.000
Authors: Stefan Möhlenkamp; Nils Lehmann; Axel Schmermund; Ulla Roggenbuck; Susanne Moebus; Nico Dragano; Marcus Bauer; Hagen Kälsch; Barbara Hoffmann; Andreas Stang; Martina Bröcker-Preuss; Michael Böhm; Klaus Mann; Karl-Heinz Jöckel; Raimund Erbel Journal: Clin Res Cardiol Date: 2009-08-20 Impact factor: 5.460
Authors: Santosh K Padala; Abhijit Ghatak; Sandeep Padala; Deborah M Katten; Donna M Polk; Gary V Heller Journal: J Nucl Cardiol Date: 2014-09-11 Impact factor: 5.952
Authors: Enrique G Artero; Andrew S Jackson; Xuemei Sui; Duck-Chul Lee; Daniel P O'Connor; Carl J Lavie; Timothy S Church; Steven N Blair Journal: J Am Coll Cardiol Date: 2014-04-02 Impact factor: 24.094
Authors: M Wojewoda; U Tyrankiewicz; P Gwozdz; T Skorka; M Jablonska; A Orzylowska; K Jasinski; A Jasztal; K Przyborowski; R B Kostogrys; J A Zoladz; S Chlopicki Journal: Sci Rep Date: 2016-04-25 Impact factor: 4.379